Item | Column Name | Data Mapping |
|---|
1 | Surname | Patients full surname |
2 | First name | Patient Demographic Data |
3 | Sex | Patient Demographic Data |
| 4 | Age | Patient age in years |
5 | >70yrs >=70yrs and no DXA or >2yrs since last DXA | Imaging Documents subject and/or description is searched for one or
more of the following terms: - BMD
- BMD (wildcard)
- Bone Mineral Densitometry
- Bone Mineral Densitometry(wildcard)
- DXA
- DXA (wildcard)
- DEXA
- DEXA (wildcard)
- Dual Energy X-Ray Absorptiometry
- Dual Energy X-Ray Absorptiometry (wildcard)
- Body Composition Scan
|
6 | Experienced a fracture since age of 50 | Colles
Femur
Humerus
Radius
Vertebra |
7 | Osteoporosis | Osteopaenia
Osteopenia
Osteoporosis
Osteoporosis - corticosteroid induced
Osteoporosis - no fracture
Osteoporosis with fracture
Post menopausal osteoporosis
Steroid induced osteoporosis
Steroid osteopathy |
8 | Minimum Trauma Fracture | Check mapping for your clinical system under Condition Mapping: |
9 | Received bone active medication in the last 5yrs | Alendronate
Risedronate
Zoledronic Acid
Strontium Ranelate
Denosumab
Sodium etidronate |
9 | Glucocorticoid drug class >7.5mg per day for >3 months | Hormones and Metabolic Products > Adrenal Hormones > Corticosteroid
> Corticosteroid-Glucocorticoid |
11 | BMI <20 | Calculated by current (not historical) Height and weight. |
12 | Hyperthyroidism | Coded Diagnosis of Hyperthyroidism or Hyperthyroidism, subclinical |
13 | Smoking | Smoking Status |
14 | Coeliac Disease | Coeliac Disease
Coeliac Disease susceptible genotype |
15 | Primary Hyperparathyroidism | |
16 | Previous treatment with aromatase inhibitor drug class | Anastrozole (Arimidex)
Letrozole (Femara)
Exemestane (Aromasin)\ |
17 | History of poor calcium intake | Calcium Deficiency diagnosis |
18 | History of low vitamin D | Vitamin D Deficiency diagnosis |
19 | Inflammatory conditions associated with bone loss | ankylosing spondylitis
Arthritis - Juvenile Rheumatoid
Arthritis - Psoriatic
Arthritis - Rheumatoid
Arthritis - Seronegative
CREST syndrome
Disseminated Lupus Erythematosis
Generalised Lupus Erythematosis
JRA (Juvenile Rheumatoid Arthritis)
Juvenile Rheumatoid Arthritis
Lupus
Lupus Erythematosus
Marie Strumpell disease
MCTD
Mixed connective tissue disease
Polymyalgia rheumatica
Polymyalgic Syndrome
psoriatic arthritis
RA (Rheumatoid Arthritis)
Reiter's disease
Reiter's syndrome
Rheumatoid Arthritis
Rheumatoid Arthritis – Juvenile
Scleroderma
Seronegative arthritis
SLE (Systemic Lupus Erythematosus)
Stills Disease
Systemic Lupus Erythematosis |
20 | CKD Please note that the diagnosis will be ignored for the indicated stage of kidney disease listed in the report! | Chronic Renal Failure
Dialysis - haemodialysis
Haemodialysis
Hemodialysis
Kidney failure - chronic
Renal dialysis
Kidney Disease – Chronic – Stage 1 -5
Renal Disease – Chronic – Stage 1 -5
Chronic Kidney Disease - Stage 1 -5
CKD (Chronic Kidney Disease) – Stage 1 -5
Chronic Renal Failure – Hyperparathyroidism
Kidney failure
Renal failure
Uraemia
Impairment - Renal
Kidney Impairment
Renal damage
Renal Impairment |
21 | Diagnosis Sarcopenia | Sarcopenia (MD3 only) |
| 22 | >70yrs >=70yrs and no DXA or >5yrs since last DXA | Imaging Documents subject and/or description is searched for one or
more of the following terms: - BMD
- BMD (wildcard)
- Bone Mineral Densitometry
- Bone Mineral Densitometry(wildcard)
- DXA
- DXA (wildcard)
- DEXA
- DEXA (wildcard)
- Dual Energy X-Ray Absorptiometry
- Dual Energy X-Ray Absorptiometry (wildcard)
- Body Composition Scan
|
| 23 | Lapsed Osteoporosis medication >12mths and <5yrs |
|